Dr. Coca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Icahn School of Medicine at Mount Sinai
New York, NY 10029Phone+1 212-241-6633
Education & Training
- Yale graduate school of arts and sciencesMS, Epidemiology and Public Health , 2006 - 2008
- Yale-New Haven Medical CenterFellowship, Nephrology, 2004 - 2008
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2004
- University of New England College of Osteopathic MedicineClass of 2001
Certifications & Licensure
- NY State License 2014 - 2026
- CT State License 2005 - 2015
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Defining Kidney Health Dimensions and their Associations with Adverse Outcomes in Persons with Diabetes and Chronic Kidney Disease.Vanessa-Giselle Peschard, Rebecca Scherzer, Michelle M Estrella, Mark J Sarnak, Simon B Ascher
Clinical Journal of the American Society of Nephrology. 2025-03-14 - Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors.Steven Menez, Kathleen F Kerr, Si Cheng, David Hu, Heather Thiessen-Philbrook
Clinical Journal of the American Society of Nephrology. 2025-03-01 - Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC.Anuradha Lala, Steven Coca, Jason Feinman, Carine E Hamo, Mona Fiuzat
Journal of the American College of Cardiology. 2025-02-25
Journal Articles
- National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug ReactionsSteven Coca, DO, American Journal of Nephrology
Press Mentions
- Screening to Predict Development of Kidney Disease Underutilized, Doctors SayJune 24th, 2022
- KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient CohortJune 6th, 2022
- XORTX Therapeutics : Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients - Form 6-KDecember 10th, 2021
- Join now to see all
Grant Support
- Mount Sinai Health System Kidney Precision Medicine ProjectICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2022–2027
- Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers”NIDDK2015–2020
- Novel serum and urinary Biomarkers of Diabetic Kidney DiseaseNIDDK2012–2017
- Long-Term Prognosis Of Acute Kidney Injury In Cardiac SurgeryNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Urinary Biomarkers For Acute Kidney Injury In Critical IllnessNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: